1. Clinical Overview
Pidotimod is a synthetic dipeptide molecule with immunomodulatory and immunostimulant properties. It acts as a biological response modifier, primarily enhancing the innate and adaptive immune response. It is widely used in the Indian context for the prevention and treatment of recurrent respiratory and urinary tract infections, particularly in vulnerable populations like children and the elderly. It is considered a safe and well-tolerated agent for long-term immunomodulation.
| Onset | Duration | Bioavailability |
|---|---|---|
| Immunomodulatory effects begin within 1-2 weeks of initiation, but full clinical benefit for infection prevention is typically observed after 4-8 weeks of continuous therapy. | The immunomodulatory effect persists for several weeks after discontinuation of therapy, contributing to its prophylactic benefit. | Approximately 45% following oral administration. |
2. Mechanism of Action
Pidotimod modulates both innate and adaptive immune responses. It stimulates the maturation and function of dendritic cells, enhances phagocytic activity of neutrophils and macrophages, and promotes the proliferation and differentiation of T-lymphocytes and B-lymphocytes. It increases the production of key cytokines (e.g., IL-2, IFN-γ) and modulates the expression of surface markers on immune cells.
3. Indications & Uses
- Prophylaxis and treatment of recurrent upper and lower respiratory tract infections (e.g., rhinosinusitis, pharyngitis, bronchitis, otitis media) in adults and children.
- Prophylaxis and treatment of recurrent urinary tract infections.
4. Dosage & Administration
Adult Dosage: 400 mg orally twice daily for the first 15 days, followed by 400 mg once daily for the next 45-60 days (total course often 60 days). For acute treatment, 800 mg twice daily for 14 days may be used.
Administration: Administer orally with or without food. The tablet should be swallowed whole with a glass of water. For prophylaxis, it is crucial to complete the full 60-day course as prescribed.
5. Side Effects
Common side effects may include:
- Gastrointestinal disturbances (nausea, diarrhea, abdominal pain).
- Headache.
- Skin rash or itching.
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Immunosuppressants (e.g., Cyclosporine, Tacrolimus, Corticosteroids) | Theoretical antagonism of Pidotimod's immunostimulant effect. | Moderate |
| Live Attenuated Vaccines | Theoretical risk of enhanced vaccine reaction or reduced vaccine efficacy; a gap of 2-4 weeks is advised. | Moderate |
| Other Immunomodulators (e.g., Levamisole, Isoprinosine) | Potential additive effect; concurrent use not recommended without medical supervision. | Moderate |
7. Patient Counselling
- DO complete the full prescribed course (often 60 days) even if you feel better.
- DO inform your doctor about all other medications and supplements you are taking.
- DO maintain good hygiene and a balanced diet to support immune health.
- DONT use Pidotimod to treat an active, severe infection without appropriate antibiotics as advised by your doctor.
- DONT stop the medication abruptly without consulting your doctor.
8. Toxicology & Storage
Overdose: No specific reports of acute overdose in humans. Based on pharmacology, symptoms may include exaggerated side effects like severe nausea, vomiting, diarrhea, and dizziness.
Storage: Store below 30°C. Protect from light and moisture. Keep the bottle tightly closed. Keep out of reach and sight of children. Do not use after the expiry date printed on the pack.